Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sara Varea
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patients with Multiple sclerosis or neuromyelitis optica
diagnosed more than a year before inclusion
Expanded Disability Status Scale between 3.0 and 8.5
all subtypes of multiple sclerosis or Neuromyelitis optica
Multiple Sclerosis patients who have previously been offered therapeutic alternatives available in indications and either decline or that after receiving treatment for at least 6 months have had an outbreak or an increase of at least 1 point on the Expanded Disability Status Scale (EDSS) (non-responders) or who have not tolerated treatment
Patients with Neuromyelitis optica (NMO) in stable immunomodulatory treatment in the past 6 months or without treatment because they are not candidates to receive it
You may not be if
Corticosteroid treatment in the last 30 days
Presence of an outbreak in the last month
Inability to perform brain Magnetic resonance imaging (with paramagnetic contrast)
Serious systemic diseases, including Hepatitis B virus, Hepatitis C Virus, and Human Immunodeficiency Virus. Uncontrolled hypertension, insulin-dependent diabetes mellitus, heart disease or kidney failure or severe respiratory
Personal history of cancer or family history of known hereditary cancer
patient participating in other experimental study in the last 3 months
women childbearing-aged that do not use effective contraceptive methods
